In the latest session, ENDRA Life Sciences Inc (NASDAQ: NDRA) closed at $0.58 down -29.29% from its previous closing price of $0.82. In other words, the price has decreased by -$0.2403 from its previous closing price. On the day, 974531 shares were traded.
Ratios:
For a deeper understanding of ENDRA Life Sciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.36 and its Current Ratio is at 3.36. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 18 ’23 when Thornton Michael Milos bought 15,000 shares for $1.65 per share. The transaction valued at 24,750 led to the insider holds 34,139 shares of the business.
DIGIANDOMENICO ANTHONY bought 83,333 shares of NDRA for $100,000 on May 02 ’23. The Director now owns 102,434 shares after completing the transaction at $1.20 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NDRA now has a Market Capitalization of 6.40M and an Enterprise Value of 3.50M.
Stock Price History:
Over the past 52 weeks, NDRA has reached a high of $2.91, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is 1.0661, while the 200-Day Moving Average is calculated to be 1.2003.
Shares Statistics:
For the past three months, NDRA has traded an average of 132.17K shares per day and 282.96k over the past ten days. A total of 11.04M shares are outstanding, with a floating share count of 10.88M. Insiders hold about 1.41% of the company’s shares, while institutions hold 1.19% stake in the company. Shares short for NDRA as of Mar 15, 2024 were 48.45k with a Short Ratio of 0.37, compared to 29.4k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.44% and a Short% of Float of 0.44%.
Earnings Estimates
There are 1 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.37 for the current quarter, with a high estimate of -$0.37 and a low estimate of -$0.37, while EPS last year was -$0.93. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.36 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$1.41 and -$1.41 for the fiscal current year, implying an average EPS of -$1.41. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
